Is Intramuscular Administration of Recombinant Human C1-Inhibitor an Alternative for the Treatment of Acute Attacks in Patients with Hereditary Angioedema?

Subjects

Subjects :

business.industry
Immunology
Hereditary angioedema
Recombinant human C1 inhibitor
medicine
Immunology and Allergy
In patient
Pharmacology
medicine.disease
business
Administration (government)

Details

ISSN :

00916749

Volume :

141

Database :

OpenAIRE

Journal :

Journal of Allergy and Clinical Immunology

Accession number :

edsair.doi...........01ebd140ebd6b9bf89010a30d55778a3

Full Text :

https://doi.org/10.1016/j.jaci.2017.12.187